Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Nanochon Chondrograft | Experimental | Mini arthrotomy or arthroscopic surgical implantation of Nanochon Chondrograft |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nanochon Chondrograft | Device | Mini arthrotomy or arthroscopic surgical implantation of Nanochon Chondrograft |
|
| Measure | Description | Time Frame |
|---|---|---|
| Serious Adverse Device Effects | Absence of Serious Adverse Device Event Effects (SADEs) through Month 12 | Month 12 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Participant is:
receiving workman's compensation
receiving prescription narcotic medication
active with litigation relating to musculoskeletal injuries or disorders
a prisoner or pending incarceration
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chief Clinical Officer | Contact | 615-483-7438 | Heather@Nanochon.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Panama Clinic | Panama City | Panama |
Undecided at this time.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided